People · Operator

Frank F. Litvack, M.D.

Named in public records as an officer, director or promoter · active 2010–2011 · Pharmaceuticals

2
Companies
2
Filings
$6.0M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
iTherx Pharma, Inc.PharmaceuticalsSeed$3.2M$120.7M2011
iTherX Pharmaceuticals, Inc.PharmaceuticalsSeed$2.8M$105.8M2010
Operator network

Frank F. Litvack, M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

John H. Friedman · 3 companies · 1 sharedJohn H. FriedmanAmanda H. Iles · 1 companies · 1 sharedAmanda H. IlesEve H. Slater · 1 companies · 1 sharedEve H. SlaterFlossie F. Wong-Staal, Ph.D. · 1 companies · 1 sharedFlossie F. Wong-S…Franklin H. Berger · 1 companies · 1 sharedFranklin H. BergerJeffrey F. McKelvy, Ph.D. · 2 companies · 2 sharedJeffrey F. McKelv…Steven B. Gerber, M.D. · 2 companies · 2 sharedSteven B. Gerber,…Flossie B. Wong-Staal, Ph.D. · 1 companies · 1 sharedFlossie B. Wong-S…John B. Friedman · 1 companies · 1 sharedJohn B. FriedmanTsvi F. Goldenberg, Ph.D. · 1 companies · 1 sharedTsvi F. Goldenber…iTherx Pharma, Inc. · $3.2M raisediTherx Pharma, Inc.iTherX Pharmaceuticals, Inc. · $2.8M raisediTherX Pharmaceutical…Frank F. Litvack, M.D.FM
Frank F. Litvack, M.D. Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Frank F. Litvack, M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Steven B. Gerber, M.D.22
Jeffrey F. McKelvy, Ph.D.22
John H. Friedman13
Amanda H. Iles11
Flossie F. Wong-Staal, Ph.D.11
Tsvi F. Goldenberg, Ph.D.11
Flossie B. Wong-Staal, Ph.D.11
John B. Friedman11
Franklin H. Berger11
Eve H. Slater11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.